Related Experiment Video
Updated: Aug 21, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Guilty as charged: B-RAF is a human oncogene
Mathew J Garnett1, Richard Marais
1Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom.
Abstract:
RAF proteins are components of a conserved signaling pathway that regulates cellular responses to extracellular signals. Despite over 20 years of research into the regulation and function of the RAF proteins, it was only realized recently that the B-RAF isoform is mutated at a high frequency in human cancer. Here we review the rapid progress made in our understanding of B-RAF as an oncogene and of its role in cancer.
Insights
Recent findings reveal BRAF (B-RAF) is a frequently mutated oncogene in human cancers. This review summarizes our understanding of BRAF
Area of Science:
- Cellular signaling pathways
- Molecular oncology
- Cancer genetics
Background:
- RAF proteins are key regulators of cellular responses to extracellular signals.
- Despite extensive research, the oncogenic role of the B-RAF isoform is a recent discovery.
- High-frequency mutations in B-RAF are observed in various human cancers.
Purpose of the Study:
- To review the recent advancements in understanding B-RAF.
- To discuss the role of B-RAF as an oncogene in human cancer.
- To highlight the significance of B-RAF mutations in cancer development.
Main Methods:
- Literature review of studies on RAF proteins and B-RAF.
- Analysis of research on B-RAF mutations and their frequency in cancer.
- Synthesis of current knowledge on B-RAF's function as an oncogene.
Main Results:
- B-RAF is a significant oncogene implicated in human cancers.
- Mutations in B-RAF occur frequently across diverse cancer types.
- Understanding B-RAF's oncogenic role has progressed rapidly.
Conclusions:
- B-RAF is a critical player in cancer development due to its frequent mutations.
- Continued research into B-RAF is essential for targeted cancer therapies.
- The discovery of B-RAF's oncogenic nature has opened new avenues in oncology.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

